Role of adiponectin in gestational diabetes mellitus: advances in mechanistic insights and early predictive potential
Yuting Chen, Feiming He, Lili Zhang, Zhongying Zhang · 2026
Read Role of adiponectin in gestational diabetes mellitus: advances in mechanistic insights and early predictive potential by Yuting Chen, Feiming He, Lili Zhang, Zhongying Zhang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13418717.txt.
Description
Chen and colleagues review adiponectin, a hormone made by fat tissue, as an early warning marker for gestational diabetes, the blood sugar disorder arising in pregnancy, in 2026 hormone research. Adiponectin usually improves insulin sensitivity, and falling levels in pregnancy track with rising diabetes risk. The review gathers evidence on how the hormone works and on its forms, above all the high-molecular-weight form considered most active. It asks whether testing it could flag at-risk mothers before standard testing.
Evidence links low adiponectin to the insulin resistance and faltering pancreas compensation at the disease's core. It also links to placental hormone interactions, nutrient transport, inflammation, and oxidative stress. Models combining adiponectin look promising for early risk ranking. Real obstacles remain: assays are not standardized, sampling timing in pregnancy varies, and groups differ. Chen concludes adiponectin can add to, but never replace, the standard oral glucose tolerance test.
Catalog record
| CREATOR | Yuting Chen, Feiming He, Lili Zhang, Zhongying Zhang |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 48 KB |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |